β-Cell Function in Subjects Spanning the Range from Normal Glucose Tolerance to Overt Diabetes: A New Analysis
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
The nature of the progressive beta-cell failure occurring as normal glucose tolerant (NGT) individuals progress to type 2 diabetes (T2DM) is incompletely understood. We measured insulin sensitivity (by a euglycemic insulin clamp) and insulin secretion rate (by deconvolution of plasma C-peptide levels during an oral glucose tolerance test) in 188 subjects [19 lean NGT (body mass index [BMI] </= 25 kg/m(2)), 42 obese NGT, 22 BMI-matched impaired glucose tolerance [IGT], and 105 BMI-matched T2DM]. Main determinants of beta-cell function on the oral glucose tolerance test were derived from a mathematical model featuring the following: 1) glucose concentration-insulin secretion dose response (glucose sensitivity), 2) a secretion component proportional to the derivative of plasma glucose concentration (rate sensitivity); and 3) a potentiation factor. When NGT and T2DM were subgrouped by 2-h plasma glucose concentrations, insulin secretion rate revealed an inverted U-shaped pattern, rising through NGT up to IGT and falling off thereafter. In contrast, beta-cell glucose sensitivity dropped in a monophasic, curvilinear fashion throughout the range of 2-h plasma glucose. Within the NGT range (2-h glucose of 4.1-7.7 mmol/liter), beta-cell glucose sensitivity declined by 50-70% (P < 0.02). Insulin sensitivity decreased sharply in the transition from lean to obese NGT and then declined further in IGT and mild T2DM to level off in the higher three quartiles of diabetic hyperglycemia. In T2DM, defective beta-cell potentiation and rate sensitivity also emerged (P </= 0.05). In the whole data set, insulin sensitivity and the dynamic parameters of beta-cell function explained 89% of the variability of 2-h plasma glucose levels. The following conclusions were reached: 1) beta-cell glucose sensitivity falls already within the NGT range in association with rising 2-h plasma glucose concentrations, although absolute insulin secretion rates increase; and 2) throughout the glucose tolerance range, dynamic parameters of beta-cell function (glucose sensitivity, rate sensitivity, and potentiation) and insulin sensitivity are independent determinants of 2-h plasma glucose levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The slope of the relationship between glucose and insulin secretion (ie, β -CGS) is a major controller of postprandial glu cose levels (23, 24).”
From Effects of Tirzepatide vs Semaglutide on β-Cell Function, Insulin Sensitivity, and Glucose Control During a Meal Test (2024) · cites this paper as [24]
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Self-citationInsulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326
Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940 · cited 2×
“5] -cell glucose sensitivity (pmol min 1 m 2 mM (1)) 147 [97] 92 [98] 55 [34] 14 [15]”
Nauck, M. A., Heimesaat, M. M., Orskov, C., Holst, J. J., Ebert, R., & Creutzfeldt, W. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116186 · Cited by 1,651
McGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435
Kahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., & Palmer, J. P. (1993) · Diabetes · doi:10.2337/diab.42.11.1663 · Cited by 1,405
Martin, B. C., Warram, J. H., Krolewski, A. S., Soeldner, J. S., Kahn, C. R., Martin, B. C., & Bergman, R. N. (1992) · The Lancet · doi:10.1016/0140-6736(92)92814-v · Cited by 1,158
Lipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications
Unger, R. H. (1995) · Diabetes · doi:10.2337/diab.44.8.863 · Cited by 1,100
Nauck, M. A., Kleine, N., �rskov, C., Holst, J. J., Willms, B., & Creutzfeldt, W. (1993) · Diabetologia · doi:10.1007/bf00401145 · Cited by 1,092 · cited 1×
“Fasting plasma insulin (pmol/liter) 20 [16] 48 [32] 74 [47] 94 [58] Insulin AUC (nmol/liter h) 22 [15] 45 [38] 65 [33] 24 [23] I/ G (pmol/mmol) 73 [84] 163 [172] 122 [140] 19 [33] Fasting ISR (pmol/min m (2)) 53 [34] 85 [53] 116 [39] 112 [71] Total IS (nmol m (2)) 30 [18] 43 [19] 47 [17] 24 [19] Insulin sensitivity (M…”
Cited by
Items 501–538 of 538
Konventionelle und kombinierte Insulintherapie bei Typ-2-Diabetes
Janka, H. U. (2006) · Der Diabetologe · doi:10.1007/s11428-006-0064-4
“Die se therapeutischen Maßnahmen sind vermutlich in allen Stadien des Typ2-Diabetes effektiv und sollten bei übergewichtigen Patienten versucht werden, auch wenn mit zunehmender Diabetesdauer ein progressiver Verlust der pankreatischen β-Zell-Funktion nachgewiesen wurde [11].”
BackgroundApproachtoTherap y in Patients With Newly Diagnosed Type 2 Diabetes
DeFronzo, R. A., & Eldor, R. (2013)
Self-citationClinical management of hyperglycaemia in type 2 diabetes
Matthews, D. R. (2015) · Wiley eBooks · doi:10.1002/9781119121725.ch13
Continuous glucose monitoring for optimising glycaemic performance in individuals without diabetes.
Thomas, F. (2017) · ORBi (University of Liège) · doi:10.26021/3044
Investigations of the Mechanisms of Diabetes Remission: A Focus on Adaptive Thermogenesis
Corley, B. (2019) · Otago University Research Archive (University of Otago) · Cited by 2
Pancreatic Ductal Adenocarcinoma and Type 2 Diabetes Mellitus: Distant Relatives or the Close Ones?
Subham, K., Mohanty, S., Jena, S., Ojha, M., & Jha, S. (2020) · Diagnostics and therapeutic advances in GI malignancies · doi:10.1007/978-981-15-5471-1_13
Avaliação do risco para diabetes mellitus tipo 2 em uma clínica no oeste do Paraná
Nakahara, K. R., Pescador, M. V. B., Pagnussat, J. V., & Gai, J. D. (2021) · Research Society and Development · doi:10.33448/rsd-v10i9.18249
Appell, C. R. (2021) · ThinkTech (Texas Tech University) · Cited by 1
(2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000235329.84906.3b
Precision Medical Management Strategies for Diabetes Remission
Kashyap, S. R., & Borgan, S. (2022) · Springer eBooks · doi:10.1007/978-3-030-98927-9_10
Hyperinsulenemia, Obesity, and T2 Diabetes: A continuum
Chawla, R. (2023) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-023-01193-5
“Hence, the author summarises that in obese T2DM individuals, the main pathogenic mechanism could be the decrease in insulin secretory capacity, while in non-obese individuals, a reduction in insulin clearance leading to hyperinsulinemia is likely to play a major role in the pathogenesis of T2DM.”
BackgroundInfluentialCommendatore, V., Faingold, C., Fenili, C., Frechtel, G. D., González, C. D., Llanos, I., Lucarelli, C., Maselli, M. D. C., Mazza, C., Puchulu, F., et al. (2023) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v57i1.676 · Cited by 8
Salmon, J. A., Magbuhat, A. L., Guerrero-Sali, R. J., Purino, F., & Macindo, J. R. B. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4515333
Moon, S. J., Hong, J. H., Kim, S. S., Kim, K., Lim, S. K., Jin, H. Y., Hwang, Y., Lee, S., Lee, K., Kang, J. G., et al. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4608008
Central Control of Glucose Homeostasis
Alonge, K. M., Francis, K. L., Richardson, N. E., & Schwartz, M. W. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch10
Effect of diabetes mellitus on treatment response in locally advanced carcinoma cervix patients
Shah, A., Kumar, D., Meedimale, S., Kaur, H., & Shukla, P. (2023) · Bengal Journal of Cancer · doi:10.4103/bjoc.bjoc_1_24
Bayesian Occam’s Razor to Optimize Metamodeling for Complex Biological SystemsPreprint
Wang, C., Zhao, J., Zheng, J., Raveh, B., He, X., & Sun, L. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.28.594654 · Cited by 1
Association of Impaired Fasting Glucose and Coronary Artery Disease in Non-diabetic Population
Abbaszadeh, S., Hafezpour, Y., Nikparvar, M., Bushehri, E., Abbasi, H., Moraghebi, M., Farshidi, H., & Kheirandish, M. (2023) · Bimonthly Journal of Hormozgan University of Medical Sciences · doi:10.34172/hmj.2023.968 · Cited by 1
Ahrtz, L. (2024) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/175148
Neuroglia in eating disorders (obesity, Prader-Willi syndrome and anorexia nervosa)
Corrêa‐da‐Silva, F., & Yi, C. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-443-19102-2.00019-3
Sun, R.-M., Dai, D.-X., Xu, F., Ling, Y., & Xie, Z. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i7.106470
Ritsinger, V., Gunnarsson, R., Melin, E. O., Hillman, M., Stogianni, A., Holmberg, S., Johansson, K., Neumark, A.-S. N., Krol, H., Rööst, M., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-095630
“Still, despite this, a number of significant associations could be established.”
Das, S. (2025) · Research Square · doi:10.21203/rs.3.rs-7297145/v1 · Cited by 1
Singh, M. P., Gupta, S., Singh, M. P., Ambrish, C., Kurmi, P. H., Gangwani, D. K., Naganna, J., Sethuraman, R., Dhumal, V., Behera, S., et al. (2025) · Advances in Therapy · doi:10.1007/s12325-025-03323-3 · Cited by 2
Pawar, A. D., Rohile, S. B., & D., S. S. (2025) · International Journal of Advanced Research in Science Communication and Technology · doi:10.48175/ijarsct-29628
Aiello, E., Grieco, G. E., Brunetti, M., Gliozzo, G., Fignani, D., Quero, G., Alfieri, S., Giuseppe, G. D., Ciccarelli, G., Dardano, A., et al. (2025) · medRxiv · doi:10.64898/2025.12.02.25341443
Self-citationPathophysiology: Loss of β-Cell Function
Ferrannini, E., & Mari, A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3314-9_2 · Cited by 1
Self-citationmTOR Inhibition: Reduced Insulin Secretion and Sensitivity in a Rat Model of Metabolic Syndrome
Rovira Juárez, J., Ramírez Bajo, M. J., Bañón Maneus, E., Moya Rull, D., Ventura Abreu Aguiarà, P., Hierro García, N., Lazo Rodríguez, M., Revuelta Vicente, I., Torres, A., Oppenheimer, F., et al. (2016) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Duc, T. Q., Di, K. N., Dang, D. K., Quynh, V. T., & Huyen, N. T. H. (2026) · CyTA - Journal of Food · doi:10.1080/19476337.2026.2613503
Pathogenesis of type 2 diabetes
Honka, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00376-9
Laget, J. (2019) · theses.fr (ABES) · doi:10.70675/ed653ea5z6ff4z4915za368z0d23f0cd9829 · Cited by 1
Akar, E. A. (2022) · theses.fr (ABES) · doi:10.70675/a7b15e3fz84e7z4915z9447zc112181e06e4
Prato, S. D., Heine, R. J., Manghi, F. P., Hsia, S. H., Valderas, E. G., Zeytinoglu, M., Razzoli, E., Kiljanski, J. I., Sharma, P., Knights, A. W., et al. (2026) · Annals of Internal Medicine · doi:10.7326/annals-25-05602
Lalama, E., Zhang, J., Schuppelius, B., Csanalosi, M., Rüther, K. J. A., Kabisch, S., Mai, K., Kraenkel, N., Latz, E., Christ, A., et al. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113382
Self-citationSvonni, E., Michanek, P., Bergsten, P., Lindåse, S. S., & Bröjer, J. T. (2026) · Journal of Veterinary Internal Medicine · doi:10.1093/jvimsj/aalag285
“9 , 28 However, CAN-treated horses exhibited lower, rather than higher, FPG and glycaemic response to IV glucose, and no evidence of T2D was obser ved, making lower glucose tolerance unlikely.”
Metadata
- Authors
- Ferrannini, E., Gastaldelli, A., Miyazaki, Y., Matsuda, M., Mari, A., & DeFronzo, R. A.
- Affiliations
- University of Pisa (IT)
- The University of Texas at San Antonio Health Science Center (US)
- National Research Council (IT)
- Corresponding author
- Ferrannini, Ele
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-01
- Volume
- 90
- Issue
- 1
- Pages
- 493-500
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1981581852
- Semantic Scholar
- 1e59c003bc095926431f049735ca1064ebb24a32
- Cited by
- 540
- References
- 45
- Citations by year
- 2026: 10 · 2025: 21 · 2024: 20 · 2023: 20 · 2022: 27 · 2021: 19 · 2020: 21 · 2019: 22 · 2018: 25 · 2017: 26 · 2016: 21 · 2015: 33 · 2014: 33 · 2013: 26 · 2012: 32
- FWCI
- 29.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 24092)
- National Center for Research Resources (M01RR01346, M01RR001346)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- beta-cell function, type 2 diabetes, impaired glucose tolerance, insulin sensitivity, insulin secretion rate, beta-cell glucose sensitivity, rate dependence, C-peptide, hyperinsulinemic-euglycemic clamp, oral glucose tolerance test, obesity, 2-hour plasma glucose
- MeSH terms
- Insulin Secretion, Adult, Blood Glucose, Cross-Sectional Studies, Diabetes Mellitus, Fatty Acids, Nonesterified, Female, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Male, Middle Aged
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.